Mount Sinai Hospital: New Formulation Of FDA-Approved Drug Shows Encouraging Results For Treating A Common Itch Condition
February 09, 2023
February 09, 2023
NEW YORK, Feb. 9 (TNSjou) -- Mount Sinai Hospital issued the following news release on Feb. 8, 2023:
Notalgia paresthetica--a nerve disorder characterized by a persistent itch in the upper back--is a common and underdiagnosed condition worldwide. To date, there are no FDA-approved treatments specifically targeting this disorder.
But a new study, published today in the New England Journal of Medicine, suggests that patients experiencing the moderate-to-severe itching ass . . .
Notalgia paresthetica--a nerve disorder characterized by a persistent itch in the upper back--is a common and underdiagnosed condition worldwide. To date, there are no FDA-approved treatments specifically targeting this disorder.
But a new study, published today in the New England Journal of Medicine, suggests that patients experiencing the moderate-to-severe itching ass . . .